Basiliximab is a monoclonal antibody that binds to the α-chain of the interleukin (IL)-2 receptor and used as induction therapy in kidney transplantation.
MoreBelimumab (LymphoStat B), a fully humanised mAb against B lymphocyte stimulator (B-LyS), is the first drug to be approved specifically for the treatment of SLE.
More